Scadden David

Track

Insider profile

Scadden David's trades of Agios Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
157.30
Quantity 36,015
Value US$2,370,331
Transaction date
Proposed sale
Price
40.00
Quantity 200
Value US$8,000
Transaction date
Proposed sale
Price
40.00
Quantity 1,400
Value US$56,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-14 2025-11-12
PlS Planned sale
88,535 +40.3%
414.69
US$692,952 		88,535 +40.3% 414.69 US$692,952
2025-10-10 2025-10-08
PlS Planned sale
62,595 -7.8%
446.03
US$693,470 		62,595 -7.8% 446.03 US$693,470
2025-10-08 2025-10-08
PrS Proposed sale
36,015
157.30
US$2,370,331 		36,015 157.30 US$2,370,331
2025-10-02 2025-09-30
PlS Planned sale
200 -1.1%
40.00
US$8,000 		200 -1.1% 40.00 US$8,000
2025-08-29 2025-08-27
PlS Planned sale
200 -1.1%
40.00
US$8,000 		200 -1.1% 40.00 US$8,000
2025-08-27 2025-08-27
PrS Proposed sale
200
40.00
US$8,000 		200 40.00 US$8,000
2025-07-15 2025-07-10
PlS Planned sale
1,400 -7.4%
40.00
US$56,000 		1,400 -7.4% 40.00 US$56,000
2025-07-10 2025-07-10
PrS Proposed sale
1,400
40.00
US$56,000 		1,400 40.00 US$56,000
2024-12-13 2024-12-11
PlS Planned sale
200 -1.3%
46.28
US$9,256 		200 -1.3% 46.28 US$9,256